The primary endpoint was median time to tumor progression . Secondary endpoints included objective tumor response rate (WHO criteria), measured every 3 mos, as well as symptom control and overall survival Results: Eighty-five patients … Read more...

A new report just published on line in Lancet Oncology is suggesting that the cell cycle progression (CCP) score — a measure of the levels of expression of selected genes that are important to cell growth — may be an important indicator … Read more...

Yao, MD, associate professor in MD Anderson’s Department of Gastrointestinal Medical Oncology , first presented the at the 2010 European Society for Medical Oncology Congress. Read more...

36.1% of the review cases experience a progression of benign tumor to malignancy, having a worse OS compared to MPNSTs arising de novo. The latter difference though did not reach statistic significance (8.46 vs 22.95 months, p = 0.140) Read more...

1 State Key Laboratory of Oncology in Southern China, Department of Radiation Oncology , Cancer Center, Sun Yat-sen University, 651 Dongfeng Road East, Guangzhou, PRC. Read more...

1Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine. 2Department of Medical Oncology , Oncology Center, Mansoura University, Al-Mansoura, Egypt. Read more...

What Type of Diagnostic Work Do Oncology Jobs Include? Read more...

Some cool Lung Cancer images: Read more...

A few nice Breast Cancer images I found: Read more...

by Barnaby Jeans

Question by Adun: How come breast cancer gets so much attention when others don’t?
I’m not saying breast cancer is not a horrible ailment but there are worse cancer’s and worse diseases but it seems to get more attention then others. One of the most common diseases no one does events for “asthma” for example and yes people do die from it. I’m saying we shouldn’t have events for breast cancer I’m just wondering why it gets so much attention when others do not. Read more...